Evidence map›Paper›PMID 23800147›Full record

ArticleBiotechnology for biofuels2013

Development of a D-xylose fermenting and inhibitor tolerant industrial Saccharomyces cerevisiae strain with high performance in lignocellulose hydrolysates using metabolic and evolutionary engineering.

Mekonnen M Demeke, Heiko Dietz, Yingying Li, María R Foulquié-Moreno, Sarma Mutturi, Sylvie Deprez, Tom Den Abt, Beatriz M Bonini, Gunnar Liden, Françoise Dumortier and 3 more

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
20.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 335 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Development of a RobustMicroorganisms · 2024
    Article
  9. Microbiology spectrum · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in bioengineering and biotechnology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. FromJournal of fungi (Basel, Switzerland) · 2023
    Review
  19. Review
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Mekonnen M Demeke *Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Belgium.
Heiko Dietz *Institute of Molecular Biosciences, Goethe-University Frankfurt, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, Germany.
Yingying LiLaboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Belgium.
María R Foulquié-MorenoLaboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Belgium.
Sarma MutturiDepartment of Chemical Engineering, Lund University, P.O. Box 124, 22100 Lund, Sweden.
Sylvie DeprezLaboratory of Enzyme, Fermentation and Brewing Technology, KAHO Sint-Lieven University College, KU Leuven Association, Gebroeders De Smetstraat 1, 9000, Ghent, Flanders, Belgium.
Tom Den AbtLaboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Belgium.
Beatriz M BoniniLaboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Belgium.
Gunnar LidenDepartment of Chemical Engineering, Lund University, P.O. Box 124, 22100 Lund, Sweden.
Françoise DumortierLaboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Belgium.
Alex VerplaetseLaboratory of Enzyme, Fermentation and Brewing Technology, KAHO Sint-Lieven University College, KU Leuven Association, Gebroeders De Smetstraat 1, 9000, Ghent, Flanders, Belgium.
Eckhard BolesInstitute of Molecular Biosciences, Goethe-University Frankfurt, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, Germany.
Johan M TheveleinLaboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Belgium.
VIB-KU Leuven Center for Microbiology · BEKU Leuven · BEGoethe University Frankfurt · DELund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe production of bioethanol from lignocellulose hydrolysates requires a robust, D-xylose-fermenting and inhibitor-tolerant microorganism as catalyst. The purpose of the present work was to develop such a strain from a prime industrial yeast strain, Ethanol Red, used for bioethanol production.

resultsAn expression cassette containing 13 genes including Clostridium phytofermentans XylA, encoding D-xylose isomerase (XI), and enzymes of the pentose phosphate pathway was inserted in two copies in the genome of Ethanol Red. Subsequent EMS mutagenesis, genome shuffling and selection in D-xylose-enriched lignocellulose hydrolysate, followed by multiple rounds of evolutionary engineering in complex medium with D-xylose, gradually established efficient D-xylose fermentation. The best-performing strain, GS1.11-26, showed a maximum specific D-xylose consumption rate of 1.1 g/g DW/h in synthetic medium, with complete attenuation of 35 g/L D-xylose in about 17 h. In separate hydrolysis and fermentation of lignocellulose hydrolysates of Arundo donax (giant reed), spruce and a wheat straw/hay mixture, the maximum specific D-xylose consumption rate was 0.36, 0.23 and 1.1 g/g DW inoculum/h, and the final ethanol titer was 4.2, 3.9 and 5.8% (v/v), respectively. In simultaneous saccharification and fermentation of Arundo hydrolysate, GS1.11-26 produced 32% more ethanol than the parent strain Ethanol Red, due to efficient D-xylose utilization. The high D-xylose fermentation capacity was stable after extended growth in glucose. Cell extracts of strain GS1.11-26 displayed 17-fold higher XI activity compared to the parent strain, but overexpression of XI alone was not enough to establish D-xylose fermentation. The high D-xylose consumption rate was due to synergistic interaction between the high XI activity and one or more mutations in the genome. The GS1.11-26 had a partial respiratory defect causing a reduced aerobic growth rate.

conclusionsAn industrial yeast strain for bioethanol production with lignocellulose hydrolysates has been developed in the genetic background of a strain widely used for commercial bioethanol production. The strain uses glucose and D-xylose with high consumption rates and partial cofermentation in various lignocellulose hydrolysates with very high ethanol yield. The GS1.11-26 strain shows highly promising potential for further development of an all-round robust yeast strain for efficient fermentation of various lignocellulose hydrolysates.

Identifiers

PMID23800147
PMCPMC3698012
OpenAlexW2141374544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.